Zhao Yu, Jing Yu, Bo Jian, Wang Shu-Hong, Wang Quan-Shun, Li Hong-Hua, Yu Li
Department of Hematology, General Hospital PLA, Beijing 100853, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):322-4.
The aim of this study was to evaluate the significance of id4 gene promotor methylation detection in NHL patients. MS-PCR method was used to detect the status of id4 gene methylation in health donors and newly diagnosed NHL patients. The results indicated that the id4 gene was unmethylated in bone marrow samples from health donors. Among 18 newly diagnosed NHL patients, including one NHL patient with bone marrow cells involved, 4 patients were found in id4 gene methylation by MS-PCR. The 14 patients with id4 gene unmethylation were in their stable status and no bone marrow involvement were found by bone marrow biopsy during the 8-month follow-up. During the follow-up, the patient with both bone marrow involvement and id4 gene methylation turned to leukemia, in 2 out of the 3 patients with id4 gene methylation but without bone marrow involvement at diagnosis, the bone marrow involvement was found at last. It is concluded that the id4 gene methylation may be an indicator for MRD in NHL patients without bone marrow involvement.
本研究的目的是评估NHL患者中id4基因启动子甲基化检测的意义。采用甲基化特异性聚合酶链反应(MS-PCR)方法检测健康供者和新诊断的NHL患者的id4基因甲基化状态。结果显示,健康供者骨髓样本中id4基因未甲基化。在18例新诊断的NHL患者中,包括1例骨髓细胞受累的NHL患者,通过MS-PCR发现4例患者存在id4基因甲基化。14例id4基因未甲基化的患者病情稳定,在8个月的随访期间骨髓活检未发现骨髓受累。随访期间,骨髓受累且id4基因甲基化的患者转为白血病,3例诊断时id4基因甲基化但无骨髓受累的患者中,有2例最终发现骨髓受累。结论是,id4基因甲基化可能是无骨髓受累的NHL患者微小残留病(MRD)的一个指标。